share_log
Breakings ·  May 25 21:43
Vera Therapeutics - Look Forward to Presenting Full 96-Week Data From Phase 2B Origin Trial, Which Are Expected in the Fourth Quarter of This Year
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment